Adamis Pharmaceuticals reported 25.4M in Market Capitalization this October of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US 0.08B 0.01B
Adma Biologics ADMA:US $ 0.39B 0.03B
Brainstorm Cell Therapeutics BCLI:US $ 0.1B 0.02B
Cara Therapeutics CARA:US $ 0.49B 0.16B
Cerulean Pharma CERU:US $ 0.12B 0.04B
Glaxosmithkline GSK:US 109.29B 0.69B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
Merk MRK:US $ 230.55B 23.1B
Pfizer PFE:US $ 294.18B 1.79B
Redhill Biopharma RDHL:US 0.13B 0B